Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherLiab,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,inventory,accountsPayable,capitalSurplus,retainedEarnings,treasuryStock,otherStockholderEquity,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,priceHint,exchange,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,exchangeDataDelayedBy,shortName,market,marketState,preMarketChange,preMarketChangePercent,preMarketTime,preMarketPrice,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (May 27, 2021) 4","Short Ratio (May 27, 2021) 4","Short % of Float (May 27, 2021) 4","Short % of Shares Outstanding (May 27, 2021) 4","Shares Short (prior month Apr 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,INMD,293747000.0,38190900,2301000,,26815000,,26643000,26373000,55445000,26771000,26771000,,,,,,69000,65524000,38753000,10079000,44000,,26746000,26643000,43545000.0,293747000.0,29266000.0,337292000.0,293747000.0,4893000.0,684000.0,64901000.0,36676000.0,223000.0,3982000.0,332026000.0,600000.0,228522000.0,22903000.0,15700000.0,7410000.0,,,,,-37443000,2321000,-37608000,9028000,-2175000,9892000,-4037000,-864000,-223000,24766000,114000,-717000,-4569000,3149000,-165000,295350000.0,en-US,US,EQUITY,True,Delayed Quote,USD,130.21,1630526403,-0.66999817,131.0,131.9263,128.68,401422,-0.5119179,128.68 - 131.9263,130.88,0.0,0.0,12,12,finmb_100060854,NasdaqGS,InMode Ltd.,USD,681064,743142,99.21001,3.2003229,31.0 - 134.2,-3.9899902,-0.029731672,31.0,134.2,1620217800,1620217800,1620217800,112.346855,2,NMS,1.159,1.7,3.27,39.819572,5.295,114.05886,16.151146,0.1416036,89.60482,40.605186,0.4531585,4972837376,76.59412,24.591125,15,America/New_York,EDT,-14400000,False,False,0,InMode Ltd.,us_market,PRE,2.7899933,2.1426873,1630573690,133.0,,,,134.2,31.0,114.06,89.6,681.06k,743.14k,38.19M,,25.45M,35.52%,55.93%,1.99M,2.91,7.87%,5.21%,1.45M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",41.20%,40.49%,20.64%,39.00%,231.19M,6.19,62.00%,175.26M,94.05M,95.24M,1.16,314.20%,293.42M,7.52,1.98M,0.67,9.05,5.30,97.87M,59.97M,Value,2069206,Healthcare,311,"InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.",Yokne'am,972 4 909 6313,1609372800,Israel,http://www.inmodemd.com,86400,Tavor Building,Medical Devices,Shaâar Yokneam PO Box 533
t-1,INMD,253963000.0,38190900,2260000,,36668000,1512000.0,36114000,26912000,64612000,35440000,35440000,,,,,,598000,75187000,39747000,10575000,1228000,,36070000,36114000,40286000.0,253963000.0,16494000.0,295761000.0,108000.0,4898000.0,3435000.0,68938000.0,35030000.0,64000.0,2135000.0,289591000.0,600000.0,191596000.0,14074000.0,14983000.0,6410000.0,101701000.0,169016000.0,-16862000.0,356000.0,-26345000,-1725000,-26380000,-15690000,-1574000,1528000,103000,-17218000,586000,41587000,109000,-112000,5667000,3108000,-35000,254561000.0,en-US,US,EQUITY,True,Delayed Quote,USD,130.21,1630526403,-0.66999817,131.0,131.9263,128.68,401422,-0.5119179,128.68 - 131.9263,130.88,0.0,0.0,12,12,finmb_100060854,NasdaqGS,InMode Ltd.,USD,681064,743142,99.21001,3.2003229,31.0 - 134.2,-3.9899902,-0.029731672,31.0,134.2,1620217800,1620217800,1620217800,112.346855,2,NMS,1.159,1.7,3.27,39.819572,5.295,114.05886,16.151146,0.1416036,89.60482,40.605186,0.4531585,4972837376,76.59412,24.591125,15,America/New_York,EDT,-14400000,False,False,0,InMode Ltd.,us_market,PRE,2.7899933,2.1426873,1630573690,133.0,,,,134.2,31.0,114.06,89.6,681.06k,743.14k,38.19M,,25.45M,35.52%,55.93%,1.99M,2.91,7.87%,5.21%,1.45M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",41.20%,40.49%,20.64%,39.00%,231.19M,6.19,62.00%,175.26M,94.05M,95.24M,1.16,314.20%,293.42M,7.52,1.98M,0.67,9.05,5.30,97.87M,59.97M,Value,2069206,Healthcare,311,"InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.",Yokne'am,972 4 909 6313,1609372800,Israel,http://www.inmodemd.com,86400,Tavor Building,Medical Devices,Shaâar Yokneam PO Box 533
t-2,INMD,232026000.0,38190900,1959000,,24091000,1512000.0,23895000,25067000,50319000,23293000,23293000,,,,,,207000,59714000,36421000,9395000,798000,,23884000,23895000,42115000.0,232026000.0,33243000.0,274141000.0,232026000.0,4070000.0,1061000.0,68835000.0,37526000.0,606000.0,2338000.0,270142000.0,600000.0,165482000.0,20954000.0,14871000.0,4283000.0,,,,,-26955000,5267000,-27058000,698000,4724000,698000,4068000,-17218000,234000,30194000,108000,1356000,-7628000,2472000,-103000,232616000.0,en-US,US,EQUITY,True,Delayed Quote,USD,130.21,1630526403,-0.66999817,131.0,131.9263,128.68,401422,-0.5119179,128.68 - 131.9263,130.88,0.0,0.0,12,12,finmb_100060854,NasdaqGS,InMode Ltd.,USD,681064,743142,99.21001,3.2003229,31.0 - 134.2,-3.9899902,-0.029731672,31.0,134.2,1620217800,1620217800,1620217800,112.346855,2,NMS,1.159,1.7,3.27,39.819572,5.295,114.05886,16.151146,0.1416036,89.60482,40.605186,0.4531585,4972837376,76.59412,24.591125,15,America/New_York,EDT,-14400000,False,False,0,InMode Ltd.,us_market,PRE,2.7899933,2.1426873,1630573690,133.0,,,,134.2,31.0,114.06,89.6,681.06k,743.14k,38.19M,,25.45M,35.52%,55.93%,1.99M,2.91,7.87%,5.21%,1.45M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",41.20%,40.49%,20.64%,39.00%,231.19M,6.19,62.00%,175.26M,94.05M,95.24M,1.16,314.20%,293.42M,7.52,1.98M,0.67,9.05,5.30,97.87M,59.97M,Value,2069206,Healthcare,311,"InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.",Yokne'am,972 4 909 6313,1609372800,Israel,http://www.inmodemd.com,86400,Tavor Building,Medical Devices,Shaâar Yokneam PO Box 533
t-3,INMD,205156000.0,38190900,1816000,,8741000,1512000.0,8588000,16149000,26070000,8105000,8105000,,,,,,161000,30765000,22660000,4695000,636000,,8580000,8588000,32862000.0,205156000.0,23786000.0,238018000.0,205156000.0,4390000.0,1376000.0,64767000.0,27812000.0,993000.0,2474000.0,233568000.0,600000.0,138639000.0,13935000.0,16227000.0,4026000.0,,,,,17836000,-4415000,17610000,549000,2386000,549000,19629000,-17218000,146000,1324000,105000,-4141000,-3045000,1846000,-226000,205756000.0,en-US,US,EQUITY,True,Delayed Quote,USD,130.21,1630526403,-0.66999817,131.0,131.9263,128.68,401422,-0.5119179,128.68 - 131.9263,130.88,0.0,0.0,12,12,finmb_100060854,NasdaqGS,InMode Ltd.,USD,681064,743142,99.21001,3.2003229,31.0 - 134.2,-3.9899902,-0.029731672,31.0,134.2,1620217800,1620217800,1620217800,112.346855,2,NMS,1.159,1.7,3.27,39.819572,5.295,114.05886,16.151146,0.1416036,89.60482,40.605186,0.4531585,4972837376,76.59412,24.591125,15,America/New_York,EDT,-14400000,False,False,0,InMode Ltd.,us_market,PRE,2.7899933,2.1426873,1630573690,133.0,,,,134.2,31.0,114.06,89.6,681.06k,743.14k,38.19M,,25.45M,35.52%,55.93%,1.99M,2.91,7.87%,5.21%,1.45M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",41.20%,40.49%,20.64%,39.00%,231.19M,6.19,62.00%,175.26M,94.05M,95.24M,1.16,314.20%,293.42M,7.52,1.98M,0.67,9.05,5.30,97.87M,59.97M,Value,2069206,Healthcare,311,"InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.",Yokne'am,972 4 909 6313,1609372800,Israel,http://www.inmodemd.com,86400,Tavor Building,Medical Devices,Shaâar Yokneam PO Box 533
